Related Experiment Video

Updated: Jan 12, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.7K

Imidacloprid contributes to bladder cancer progression: preliminary evidence based on network toxicology, machine

Jie Ming1,2, Song Jin1,2, Zhanliang Liu1,2

  • 1Department of Urology, Beijing Friendship Hospital, Capital Medical University, No.95, Yong'an Road, Xicheng District, Beijing, 100050, China.

BMC Pharmacology & Toxicology
|October 31, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Bladder cancerImidaclopridMachine learningMolecular dockingNetwork toxicologyRisk stratification

More Related Videos

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.8K
Determination of the Absorption, Translocation, and Distribution of Imidacloprid in Wheat06:11

Determination of the Absorption, Translocation, and Distribution of Imidacloprid in Wheat

Published on: April 28, 2023

2.3K

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.9K